Etiology of intracerebral hemorrhage during pregnancy or puerperium: A nationwide study.

intracerebral hemorrhage pregnancy puerperium risk factors stroke

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
02 Aug 2023
Historique:
revised: 25 07 2023
received: 22 05 2023
accepted: 26 07 2023
pubmed: 3 8 2023
medline: 3 8 2023
entrez: 2 8 2023
Statut: aheadofprint

Résumé

Intracerebral hemorrhage during pregnancy or puerperium (pICH) is one of the leading causes of maternal death worldwide. However, limited epidemiological data exist on the etiology and outcomes of pICH, which are required to guide prevention and treatment. A retrospective nationwide cohort study and a nested case-control study were performed in Finland for 1987-2016. We identified women with incident pICH by linking the Medical Birth Register (MBR) and the Hospital Discharge Register (HDR). The clinical details were collected from patient records. Three matched controls with a pregnancy without ICH were selected for each case from the MBR. In total, 49 pICH cases were identified. Half of these cases occurred during pregnancy, and the other half during peripartum and puerperium. Based on SMASH-U (structural vascular lesion, medication, amyloid angiopathy, systemic disease, hypertension, undetermined) classification, 35.4% of the patients had a systemic disease, most commonly preeclampsia, eclampsia, or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome; 31.3% had a structural vascular lesion; 31.3% had undetermined etiology; and one patient (2.1%) had hypertension. The most important risk factor was hypertensive disorders of pregnancy (HDPs; odds ratio = 3.83, 95% confidence interval = 1.60-9.15), occurring in 31% of the cases. Maternal mortality was 12.5%, and 20.9% of the surviving women had significant disability (modified Rankin Scale = 3-5) 3 months after pICH. Women with systemic disease had the worst outcomes. Even in a country with a comprehensive pregnancy surveillance system, the maternal mortality rate for pICH is high, and the sequelae are severe. Early recognition and treatment of the key risk factor, HDPs, are crucial to help prevent this serious pregnancy complication.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Intracerebral hemorrhage during pregnancy or puerperium (pICH) is one of the leading causes of maternal death worldwide. However, limited epidemiological data exist on the etiology and outcomes of pICH, which are required to guide prevention and treatment.
METHODS METHODS
A retrospective nationwide cohort study and a nested case-control study were performed in Finland for 1987-2016. We identified women with incident pICH by linking the Medical Birth Register (MBR) and the Hospital Discharge Register (HDR). The clinical details were collected from patient records. Three matched controls with a pregnancy without ICH were selected for each case from the MBR.
RESULTS RESULTS
In total, 49 pICH cases were identified. Half of these cases occurred during pregnancy, and the other half during peripartum and puerperium. Based on SMASH-U (structural vascular lesion, medication, amyloid angiopathy, systemic disease, hypertension, undetermined) classification, 35.4% of the patients had a systemic disease, most commonly preeclampsia, eclampsia, or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome; 31.3% had a structural vascular lesion; 31.3% had undetermined etiology; and one patient (2.1%) had hypertension. The most important risk factor was hypertensive disorders of pregnancy (HDPs; odds ratio = 3.83, 95% confidence interval = 1.60-9.15), occurring in 31% of the cases. Maternal mortality was 12.5%, and 20.9% of the surviving women had significant disability (modified Rankin Scale = 3-5) 3 months after pICH. Women with systemic disease had the worst outcomes.
CONCLUSIONS CONCLUSIONS
Even in a country with a comprehensive pregnancy surveillance system, the maternal mortality rate for pICH is high, and the sequelae are severe. Early recognition and treatment of the key risk factor, HDPs, are crucial to help prevent this serious pregnancy complication.

Identifiants

pubmed: 37532682
doi: 10.1111/ene.16012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Carl-Johan von Troils Memorial Fund
Organisme : The Emil Aaltonen Foundation
Organisme : Maire Taponen Foundation
Organisme : Neurocenter, Helsinki University Hospital
Organisme : Competitive state research funding for the expert responsibility area of Helsinki and Uusimaa Hospital District

Informations de copyright

© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Miller EC. Preeclampsia and cerebrovascular disease. Hypertension. 2019;74(1):5-13. doi:10.1161/hypertensionaha.118.11513
Vangen S, Bødker B, Ellingsen L, et al. Maternal deaths in the Nordic countries. Acta Obstet Gynecol Scand. 2017;96(9):1112-1119. doi:10.1111/aogs.13172
Meeks JR, Bambhroliya AB, Alex KM, et al. Association of Primary Intracerebral Hemorrhage with Pregnancy and the postpartum period. JAMA Netw Open. 2020;3(4):e202769. doi:10.1001/jamanetworkopen.2020.2769
Karjalainen L, Tikkanen M, Rantanen K, et al. Stroke in pregnancy and puerperium: validated incidence trends with risk factor analysis in Finland 1987-2016. Neurology. 2021;96(21):e2564-e2575. doi:10.1212/wnl.0000000000011990
Cantu-Brito C, Arauz A, Aburto Y, Barinagarrementeria F, Ruiz-Sandoval JL, Baizabal-Carvallo JF. Cerebrovascular complications during pregnancy and postpartum: clinical and prognosis observations in 240 Hispanic women. Eur J Neurol. 2011;18(6):819-825. doi:10.1111/j.1468-1331.2010.03259.x
Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol. 2020;17(11):718-731. doi:10.1038/s41569-020-0390-z
Bateman BT, Schumacher HC, Bushnell CD, et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology. 2006;67(3):424-429. doi:10.1212/01.wnl.0000228277.84760.a2
Liang ZW, Lin L, Gao WL, Feng LM. A clinical characteristic analysis of pregnancy-associated intracranial haemorrhage in China. Sci Rep. 2015;5:9509. doi:10.1038/srep09509
Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18(4):290-295. doi:10.1159/000080354
Jaigobin C, Silver FL. Stroke and pregnancy. Stroke. 2000;31(12):2948-2951. doi:10.1161/01.str.31.12.2948
Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012;43(10):2592-2597. doi:10.1161/strokeaha.112.661603
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. doi:10.1016/s0140-6736(07)61602-x
Charidimou A, Schmitt A, Wilson D, et al. The cerebral Haemorrhage anatomical RaTing inStrument (CHARTS): development and assessment of reliability. J Neurol Sci. 2017;372:178-183. doi:10.1016/j.jns.2016.11.021
Broderick JP, Adeoye O, Elm J. Evolution of the modified Rankin scale and its use in future stroke trials. Stroke. 2017;48(7):2007-2012. doi:10.1161/strokeaha.117.017866
Gestational Hypertension and Preeclampsia. ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237-e260. doi:10.1097/aog.0000000000003891
Hypertension and preeclampsia during pregnancy. Helsinki: the Finnish medical society Duodecim. December 2, 2021. Accessed: July 11, 2023. https://www.kaypahoito.fi/hoi50128
Swartz RH, Cayley ML, Foley N, et al. The incidence of pregnancy-related stroke: a systematic review and meta-analysis. Int J Stroke. 2017;12(7):687-697. doi:10.1177/1747493017723271
Tang CH, Wu CS, Lee TH, et al. Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke. 2009;40(4):1162-1168. doi:10.1161/strokeaha.108.540880
Yoshimatsu J, Ikeda T, Katsuragi S, et al. Factors contributing to mortality and morbidity in pregnancy-associated intracerebral hemorrhage in Japan. J Obstet Gynaecol Res. 2014;40(5):1267-1273. doi:10.1111/jog.12336
Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in pregnancy study group. Stroke. 1995;26(6):930-936. doi:10.1161/01.str.26.6.930
Yoshida K, Takahashi JC, Takenobu Y, Suzuki N, Ogawa A, Miyamoto S. Strokes associated with pregnancy and puerperium: a Nationwide study by the Japan stroke society. Stroke. 2017;48(2):276-282. doi:10.1161/strokeaha.116.014406
Nam HH, Jang DK, Cho BR. Complications and risk factors after digital subtraction angiography: 1-year single-center study. J Cerebrovasc Endovasc Neurosurg. 2022;24(4):335-340. doi:10.7461/jcen.2022.E2022.05.001
van Asch CJ, Velthuis BK, Rinkel GJ, et al. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015;351:h5762. doi:10.1136/bmj.h5762
Martí-Fàbregas J, Prats-Sánchez L, Guisado-Alonso D, Martínez-Domeño A, Delgado-Mederos R, Camps-Renom P. SMASH-U versus H-ATOMIC: a head-to-head comparison for the etiologic classification of intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2018;27(9):2375-2380. doi:10.1016/j.jstrokecerebrovasdis.2018.04.026

Auteurs

Teresa Vest (T)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Kirsi Rantanen (K)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Liisa Verho (L)

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Karoliina Aarnio (K)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Aino Korhonen (A)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Anna Richardt (A)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Daniel Strbian (D)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Mika Gissler (M)

Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Region Stockholm, Academic Primary Health Care Centre, Stockholm, Sweden.

Hannele Laivuori (H)

Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Department of Obstetrics and Gynecology, Tampere University Hospital and Tampere University, Faculty of Medicine and Health Technology, Center for Child, Adolescent, and Maternal Health Research Tampere, Tampere, Finland.

Minna Tikkanen (M)

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Petra Ijäs (P)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Classifications MeSH